Nephraegis Therapeutics is an early stage biotech developing a series of kidney therapies. The lead New Medical Entity, NPH-022, has been significantly de-risked for a program at this stage. Nephraegis welcomes inquiries from venture capital groups, angel investors, incubators, and companies interested in partnering.Nephraegis is Fighting AKI through its development of a family of proprietary drug candidates that have great ...
Nephraegis Therapeutics is an early stage biotech developing a series of kidney therapies. The lead New Medical Entity, NPH-022, has been significantly de-risked for a program at this stage. Nephraegis welcomes inquiries from venture capital groups, angel investors, incubators, and companies interested in partnering.Nephraegis is Fighting AKI through its development of a family of proprietary drug candidates that have great promise to prevent AKI.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.